Biosciences

Driven by innovation and investment, some of the world’s leading biotech, bioscience, and pharmaceutical companies have already made North Fulton their home — contributing to the $27 billion economic impact the life science industry generates across Georgia.

Boston Scientific, a Massachusetts-based, minimally invasive healthcare technology company with close to 60,000 employees across six continents, invested $108 million in Johns Creek, opening a 200,000-square-foot manufacturing and research facility in 2025 that now employs close to 300.

Kuro Bioscience, a Swiss biotechnology company specializing in spinal fusion biologics, operates its major U.S. headquarters in Roswell and began leasing a 50,000-square-foot manufacturing facility there in 2025, with plans for a larger long-term base.

Boehringer Ingelheim, one of the largest pharmaceutical companies manufacturing products in Georgia, leads in animal health innovation from its 73,000-square-foot office in Medley, Johns Creek’s premier 42-acre mixed-use community. The facility is soon to become the company’s U.S. Animal Health headquarters, and will employ nearly 500 in 2026.

Additional pharmaceutical companies, including Acella and Avion Pharmaceuticals, also do business in Alpharetta, GA, producing everything from cough formula and dermatology products to nutritional and prenatal supplements.

Talent doesn’t just find its way to North Fulton. It’s where ambitious students get cultivated into experts in their fields.

The Atlanta metro area employs more than 24,000 people in biotech-related occupations, and Johns Creek alone was home to an estimated 4,000 life science employees back in 2021 a number that’s seen a steady increase in recent years.

That growth doesn’t happen without a strong pipeline feeding it. Gwinnett Technical College’s Bioscience Technology program prepares students for careers spanning laboratory research, pharmaceuticals, and bio-manufacturing.

Georgia State University adds serious depth, too, with more than 2,300 undergraduates and 200-plus graduate students in its Department of Biology, backed by research expertise in cell and molecular biology, metabolic disorders, microbial genetics, and virology — work that pulled in $6.9 million in research grants in 2018 alone.

The North Fulton Economic Alliance keeps this pipeline sharp, partnering regularly with these institutions and regional bioscience employers to ensure the alignment of in-demand skillsets and curriculum.

Bioscience companies need infrastructure, community, and proximity to resources that fuel growth. Georgia Life Sciences, the state’s nonprofit membership organization, connects business, academia, and government to drive policy, collaboration, and industry growth. Its annual Summit, held right in Sandy Springs, brings together hundreds of leaders, researchers, and investors for two days of connection and discovery.

North Fulton is also investing in its bioscience industry. Johns Creek and Alpharetta were both recently recognized as two of Georgia’s first BioReady communities, with more than 20,000 square feet of zoned biotech space and shovel-ready land available in parcels of at least 3 acres.

Our location within metro Atlanta only strengthens our case as a hub for biosciences — offering proximity to the CDC’s national headquarters, Georgia Tech and Emory’s joint biomedical engineering program (ranked No. 4 in the nation), and Georgia Tech’s Advanced Technology Development Center which connects Atlanta biotech startup companies seeking early employees to world-class talent, mentoring, funding, pilot opportunities with corporate partners, and more.